Clinical Trials Browser

Phase 3 × INDUSTRY × olverembatinib × Clear all

NCT06423911 2025-06-03

POLARIS-2

Phase 3 Recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT06640361 2024-12-27

A Study of Olverembatinib in SDH-deficient GIST.

Phase 3 Recruiting

GIST